CARY, N.C.--()--Biologics, an integrated oncology management company, has announced the addition of Cassie Kearney to its Oncology Liaison team. Kearney brings to Biologics over 10 years of experience in oncology pharmaceutical sales and will be supporting oncology providers in the Midwest, primarily in the Chicago metro area.
“I am excited for the opportunity to support Biologics in providing oncology care to patients”
“We are growing at a significant pace and Cassie’s direct presence is an important component to our growth in the Midwest,” said Stuart Frantz, President & CEO. “Cassie’s oncology experience and passion for helping others are a natural fit with our culture at Biologics.”
The Oncology Liaison group supports and maintains relationships with oncology providers throughout the country. By working directly with Biologics’ Oncology Pharmacy and Patient Access Services, they are able to facilitate timely 360-degree communication back to a provider’s office. The team helps align all stakeholders involved in a patient’s care which saves critical time for providers, ultimately allowing for more time spent treating patients.
“I am excited for the opportunity to support Biologics in providing oncology care to patients,” said Kearney. “The team at Biologics has a genuine desire to not only help patients, but also the providers who treat them. I look forward to helping expand their efforts in aligning cancer care for patients.”
About Biologics: Biologics, Inc. is an oncology services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes – clinical, emotional and financial. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to oncology care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing oncology environment and supports patients across all treatment modalities, while providing clinical outcomes and informatics reporting that allow for informed decision making. Since it was founded in 1994, Biologics has been dedicated to improving the lives of those fighting cancer. Privately held, Biologics maintains headquarters and operations in Cary, North Carolina.

